Uveitis
📧 Sign up to get email alerts when something new happens for Uveitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Factors Affecting Aqueous Humor Outflow Facility in Patients with Uveitis
This clinical trial studied factors affecting aqueous humor outflow facility in patients with uveitis and glaucoma. The study has been withd…
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis [Phase 1, Phase 2]
A Phase I/IIa trial investigating iontophoresis for the treatment of uveitis has been withdrawn.
-
EMA withdrawal · 2021-01-29EMA Withdrawn: Halimatoz (adalimumab) — Sandoz GmbH
The EMA withdrew Halimatoz (adalimumab) supplied by Sandoz GmbH from the market.
-
CLINICAL_TRIALS withdrawal · 2020-09-29Clinical Trial Update: Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis [Phase 3]
Phase 3 extension study for AIN457 in active non-infectious uveitis was withdrawn.
-
EMA withdrawal · 2020-03-25EMA Withdrawn: Kromeya (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA has withdrawn Kromeya (adalimumab) from Fresenius Kabi Deutschland GmbH, effective 2019, affecting multiple inflammatory diseases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
CLINICAL_TRIALS withdrawal · 2019-02-07Clinical Trial Update: Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema [Phase 4]
A Phase 4 clinical trial comparing posterior subtenon versus intravitreal injection of triamcinolone acetonide for uveitic cystoid macular e…
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Autofluorescence in Uveitic and Diabetic Macular Edema
A clinical trial assessing autofluorescence in uveitic and diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Study of FTY720 in Patients With Uveitis [Phase 2]
A Phase 2 study of FTY720 (fingolimod) in acute noninfectious uveitis has been withdrawn.
-
EMA withdrawal · 2016-09-30EMA Application withdrawn: Opsiria (sirolimus) — Santen Oy
The EMA withdrew the application for Opsiria (sirolimus) by Santen Oy for uveitis.
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids [Phase 2]
A Phase 2 trial evaluating ranibizumab or steroids for uveitic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-06Clinical Trial Update: Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis [Phase 3]
A Phase 3 trial evaluating long-term use of AIN457 for uveitis has been withdrawn.
-
EMA withdrawal · 2011-10-24EMA Application withdrawn: Luveniq (voclosporin) — Lux Biosciences GmbH
The EMA withdrew the Luveniq (voclosporin) application from Lux Biosciences GmbH for the therapeutic area of uveitis.